Main Article Content

Светлана Владимировна Шрамко
Олег Иванович Бондарев
Елена Юрьевна Коваль
Анна Юрьевна Лоскутова
Татьяна Карловна Подтуркина
Евгения Юрьевна Шишея
Алексей Иванович Станков
Ольга Геннадьевна Елдинова

Abstract

A comparative study of the expression of antibodies to the cell proliferative activity marker Ki-67 and antiapoptotic protein Bcl-2 in the tissue of leiomyosarcoma, ordinary uterine fibroids and cell uterine fibroids in isolated and associated with adenomyosis variants.

Objective. 113 patients (32 patients with ordinary uterine fibroids, 26 patients with cell isolated uterine fibroids, 12 patients with isolated adenomyosis, 33 patients with uterine fibroids associated with adenomyosis, 10 patients with leiomyosarcoma of uterus).

Methods. Pathohistological and immunohistochemical research into the tissue of uterus with determination of expression of antibodies to proteins Ki-67 and Bcl-2.

Results. Spots of isolated adenomyosis and nodes of ordinary uterine fibroids are characterised by predominance of expression of antibodies to Bcl-2 over the level of expression to Ki-67. Predominance of Ki-67 indicators over Bcl-2 is determined in the tissue of leiomyosarcoma. The expression of markers of proliferative and antiapoptotic activity is determined as equal in spots of combined pathology and cell myomatous nodes.

Conclusions: The growth of ordinary myomatous nodes and isolated adenomyosis is connected with suppression of apoptosis, progression of leiomyosarcoma of uterus is connected with increased proliferation. Equivalence of proliferation and apoptosis in cell nodes and uterine fibroids associated with adenomyosis testifies to multifactorial and little studied mechanisms of tissue growth, which can be considered as one of the reasons of compicated drug and surgical treatment and tendency to recurrence.

Keywords

uterine fibroids, adenomyosis, leiomyosarcoma, Ki-67, Bcl-2

Author Biographies

Светлана Владимировна Шрамко,
candidate of medical sciences, docent, department of obstetrics and gynecology
Олег Иванович Бондарев,

Oleg I. Bondarev

Candidate of Medical Sciences, head of the research laboratory for pathological anatomy

Елена Юрьевна Коваль,
deputy chief physician for obstetrics and gynecology
Анна Юрьевна Лоскутова,
head of the gynecological department N 1
Татьяна Карловна Подтуркина,
the doctor, gynecology of the gynecological department № 1
Евгения Юрьевна Шишея,
the doctor, gynecology of the gynecological department N 1
Алексей Иванович Станков,
anesthetist, department of anesthesiology and intensive
Ольга Геннадьевна Елдинова,
deputy chief

Article Details

Information about financing and conflict of interests

The study had no sponsorship.
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.

How to Cite

Шрамко, С. В., Бондарев, О. И., Коваль, Е. Ю., Лоскутова, А. Ю., Подтуркина, Т. К., Шишея, Е. Ю., Станков, А. И., & Елдинова, О. Г. (2019). BIOLOGICAL MARKERS OF THE Ki-67 CELL CYCLE AND Bcl-2 IN MYOMA, ADENOMYOSIS, AND LEIOMYOSARCOMA UTERI. Medicine in Kuzbass, 18(3), 20-24. https://mednauki.ru/index.php/MK/article/view/364

References

Puchar A, Feyeux C, Luton D, Koskas M. Therapeutic management of uterine fibroid tumors. Minerva Gynecol. 2016; 68(4): 466-476

Khan KN, Fujishita A, Kitajima M, Masuzaki H, Nakashima M, Kitawaki J. Biological differences between functionalis and basalis endometria in women with and without adenomyosis. Eur J Obstet Gynecol Reprod Biol. 2016; 203: 49-55. doi: 10.1016/j.ejogrb.2016.05.012

Nezhat C, Li A, Abed S, Balassiano E, Soliemannjad R, Nezhat A et al. Strong Association Between Endometriosis and Symptomatic Leiomyomas. JSLS. 2016; 20(3): e2016.0005. doi: 10.4293/JSLS.2016.00053

Liao XH, Li JY, Dong XM, Wang X, Xiang Y, Li H et al. ERα inhibited myocardin-induced differentiation in uterine fibroids. Exp Cell Res. 2017; 350(1): 73-82. doi: 10.1016/j.yexcr.2016.11.007

Vachhani P, Bose P, Rahmani M, Grant S. Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML. Physiol Genomics. 2014; 46(13): 448-456. doi:10.1152/physiolgenomics.00173.2013

Edlich F. BCL-2 proteins and apoptosis: recent discoveries and unknown. Biochem Biophys Res Commun. 2018; 500(1): 26-34. doi: 10.1016/j.bbrc.2017.06.190

Davids MS, Letai A.Targeting the B-cell lymphoma/leukemia 2 family in cancer. J Clin Oncol. 2012; 30(25): 3127-3135. doi: 10.1200/JCO.2011.37.0981 30

Plewka A, Plewka D, Madej P, Nowaczyk G, Sieron-Stoltny K, Jakubiec-Bartnik B. Processes of apoptosis and cell proliferation in uterine myomas originating from reproductive and perimenopausal women. Folia Histochem Cytobiol. 2011; 49(3): 398-404

Kogan EA, ZHarkov NV, Askol'skaya SI, Popov YuV, Krot MA, Demura TA. Mechanisms of growth and morphological structure of large uterine leiomyoma. Archives of pathology. 2018; 80(5): 16-22. Russian (Коган Е.А., Жарков Н.В., Аскольская С.И., Попов Ю.В, Крот М.А., Демура Т.А. Механизмы роста и особенности морфологического строения лейомиомы матки большого размера //Архив патологии. 2018. Т. 80, № 5. С. 16-22.) doi: 10.17116/patol20188005116

Orazov MR, Sulaeva EN, Nosenko ON. Some pathomorphological changes in the myometrium of women with adenomyosis, accompanied by chronic pelvic pain syndrome. Moscow Surgical Journal. 2015; 3(43): 20-23. Russian (Оразов М.Р., Сулаева Е.Н., Носенко О.Н. Некоторые патоморфологические изменения в миометрии женщин с аденомиозом, сопровождающимся синдромом хронической тазовой боли //Московский хирургический журнал. 2015. № 3(43). С. 20-23)

Manxhuka-Kerliu S, Kerliu-Saliu I, Sahatciu-Meka V, Bodner K, Shahini L. Atypical uterine leiomyoma: a case report and review of the literature. J Med Case Rep. 2016; 10: 22. doi: 10.1186/s13256-016-0800-3

Lusby K, Savannah KB, Demicco EG, Zhang Y, Ghadimi MP, Young ED et al. Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience. Ann Surg Oncol. 2013; 20(7): 2364-2372. doi: 10.1245/s10434-012-2834-0

Taniguchi F, Kaponis A, Izawa M, Kiyama T, Deura I, Ito M еt el. Apoptosis and endometriosis. Front Biosci (Elite Ed). 2011; 3:648−62

Stănescu AD, Nistor E, Sajin M, Stepan AE. Immunohistochemical analysis in the diagnosis of uterine myometrial smooth muscle tumors. Rom J Morphol Embryol. 2014; 55(3 Suppl): 1129-1136

Boricheva DA, Macarskaya MD, SHepovalova NS. Uterine fibroids as a consequence of hormonal imbalance. Synergy of Sciences. 2018; 20: 650-663. Russian (Боричева Д.А., Мацарская М.Д., Шеповалова Н.С. Миома матки как следствие гормонального дисбаланса //Синергия Наук. 2018. № 20. С. 650-663)

Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath RB. Epidemiology of uterine fibroids: a systematic review. JOG. 2017; 124(10): 1501-1512. doi: 10.1111/1471-0528.14640

Downloads

Download data is not yet available.

Most read articles by the same author(s)

1 2 3 > >>